FREE SHIPPING ON ORDERS OVER $300!
Tirzepatide 60mg

Tirzepatide 60mg

Lyophilized powder · 60mg per vial · ≥99% purity (HPLC / MS)

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide studied for its effects on incretin signaling, glucose-dependent insulinotropic pathways, and metabolic regulation. For laboratory research use only — not for human consumption.

$380.00
  • ≥99% purity, HPLC / MS verified
  • Certificate of analysis on request
  • Made & shipped in the USA
  • Ships same business day if paid before 12PM PST (Mon–Fri)
  • Discreet, temperature-safe packaging with tracking
  • Free shipping on orders over $300

Specifications & Documentation

CompoundTirzepatide
Strength60mg
Molecular FormulaC
FormLyophilized powder
Purity≥99% (HPLC / MS verified)
GradeResearch use only

Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Its structure is based on the native GIP sequence with modifications — including a C20 fatty diacid moiety attached via a linker — that extend half-life and confer activity at both incretin receptors.

In published research, tirzepatide has been investigated for its unique pharmacological profile as the first characterized dual GIP/GLP-1 receptor agonist. Studies have examined its effects on incretin signaling cascades, pancreatic beta-cell function, glucose homeostasis pathways, gastric motility, and central appetite-regulating circuits. Its dual mechanism distinguishes it from single-receptor GLP-1 agonists studied previously in the literature.

Research areas exploring tirzepatide include:

  • Incretin receptor pharmacology and signaling
  • Glucose-dependent insulinotropic mechanisms
  • Energy balance and metabolic regulation models
  • Comparative studies with single-agonist GLP-1 analogs
  • Receptor binding, internalization, and downstream signaling
  • Peptide pharmacokinetics and fatty acid conjugation chemistry

Product Specifications

  • Peptide: Tirzepatide
  • Quantity: 60mg per vial
  • Type: Dual GIP/GLP-1 receptor agonist
  • Amino acid length: 39 residues
  • Modification: C20 fatty diacid via γGlu-2xOEG linker at Lys20
  • Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
  • Molecular weight: ~4813.5 g/mol
  • Purity: ≥98% (HPLC verified)
  • Form: Lyophilized powder
  • Storage: Store at -20°C, protect from light and moisture; reconstituted solutions refrigerated

Disclaimer: This product is intended for laboratory and research purposes only. It is not a drug, food, or cosmetic, and is not intended for human or animal consumption, diagnostic use, or therapeutic application. This product is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.